HGF and cancer: MET (Mesenchymal-Epithelial Transition) oncogene, also called Hepatocyte Growth Factor Receptor (HGF), is a receptor tyrosine kinase that appears to be deregulated in many human cancers [45], such as breast, colorectal, lung, pancreatic, hepatic and—not least—gastric cancer.